Biocartis: Roger Moody, Herman Verrelst, Christian Reinaudo

Roger Moody has been appointed as CEO of Biocartis, effective April 24, succeeding Herman Verrelst, who will become executive chairman of the board of directors, a new position. Moody will also join the board of directors, pending approval by the company's shareholders. Prior to Biocartis, he was CEO of GlySure, as well as CFO of Nanosphere (now part of DiaSorin), Clinical Genomics, and Talis Biomedical. Christian Reinaudo, until now chairman of Biocartis' board, will become lead independent director.